SEC Filings

XTANT MEDICAL HOLDINGS, INC. filed this Form DEF 14A on 12/08/2017
Entire Document



Family Relationships


There are no family relationships between or among our directors, executive officers, or persons nominated or chosen by the Company to become directors or executive officers not disclosed above.




The following table sets forth information regarding the beneficial ownership of our common stock as of December 5, 2017 by (a) each of our directors and named executive officers, (b) all of our current directors and executive officers as a group, and (c) each person who is known by us to beneficially own more than 5% of our common stock.


Name and Address of Beneficial Owner 

Number of





Percentage of

Shares Beneficially


Directors and Named Executive Officers(1):          
Carl O’Connell   75,000(4)   * 
Kent Swanson   456,794(5)   2.5%
Michael Lopach   73,741(6)   * 
Paul Buckman   20,101(7)   * 
John Deedrick   56,550(8)   * 
Eric Timko   29,700(9)   * 
Rudy Mazzocchi   29,700(10)   * 
David Kirschman, M.D.   1,697,063(11)   9.3%
All executive officers and directors as a group (8 persons)   2,438,649    13.4%
Five Percent Stockholders:          
OrbiMed Advisors LLC   1,815,483(12)   9.99%
601 Lexington Ave., 54th Floor          
New York, NY 10022          
Kenneth J. Hemmelgarn, Jr. Revocable Living Trust dated February 9, 1998   1,272,796(13)   7.0%
9485 Gulfshore Drive, B-201          
Naples, FL 34108          
Brian J. Hemmelgarn Revocable Living Trust dated February 9, 1998   1,272,796(14)   7.0%
P.O. Box 421          
15643 Captive Drive          
Captiva, FL 33924          
* Less than 1% of outstanding shares of common stock.          


(1)The address for directors and named executive officers is c/o Xtant Medical Holdings, Inc., 664 Cruiser Lane, Belgrade, Montana 59714.


(2)Unless otherwise indicated, includes shares owned by a spouse, minor children and relatives sharing the same home, as well as entities owned or controlled by the named person. Also includes shares that the named person has the right to acquire within 60 days after December 5, 2017, by the exercise or conversion of any warrant, stock option or convertible preferred stock. Unless otherwise noted, shares are owned of record and beneficially by the named person and the persons named in the table have sole voting and investment power with respect to the shares beneficially owned by them as set forth opposite their respective names.